Other · DOL Form 5500 · 2022

The Leukemia & Lymphoma Society, Inc. 403(b) Plan Retirement Plan

Data updated 2026-08-11

$97M
Total assets
911
Participants
93rd
Percentile by assets
$106,705
Avg per participant
PlainRetire home → About this data

Official DOL plan name: The Leukemia & Lymphoma Society, Inc. 403(b) Plan · Sponsored by The Leukemia & Lymphoma Society, Inc. 403(b) Plan · New York · Healthcare & Social Assistance

$97M in assets, 911 participants

The Leukemia & Lymphoma Society, Inc. 403(b) Plan's The Leukemia & Lymphoma Society, Inc. 403(b) Plan reported $97M in total assets and 911 participants in its 2022 DOL Form 5500 filing, ranking in the 93rd percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.

  • 93rd percentile by assets (of 139,126 plans)
  • #18,781 in Healthcare & Social Assistance (20,060 peers)

Where The Leukemia & Lymphoma Society, Inc. 403(b) Plan sits by assets

The Leukemia & Lymphoma Society, Inc. 403(b) Plan sits in the top 10% of all filed plans by assets, $97M for 911 participants (~$106,705/participant), down 14.2% in 2022.

$97M
total plan assets (2022 EOY)
911
covered participants
93rd
percentile by assets (of 139,126 plans)
$106,705
avg assets per participant

The plan reported a net loss of $16M for the year, a single-year figure driven by markets and benefit payments, not a measure of plan health.

The Leukemia & Lymphoma Society, Inc. 403(b) Plan vs the 2022 asset distribution

By assets, The Leukemia & Lymphoma Society, Inc. 403(b) Plan outranks 93% of the 139,126 plans that filed a Form 5500 for the 2022 plan year, and holds roughly 1.0x the national average plan size of $100M (721 average participants).

Scale-class filing particulars (2022)

Total Assets (Beginning of Year)$113M
Net Assets (End of Year)$97M
Net Income-$16M
Employer EIN135644916
Plan Effective Date1989-01-01
Filing StatusFILING RECEIVED

Sponsor Plan History (The Leukemia & Lymphoma Society, Inc. 403(b) Plan)

$80M$100M$120M$140M 202220232024 $97.2M $135M ▲ +38.6%
Total plan assets by year, all The Leukemia & Lymphoma Society, Inc. 403(b) Plan plans on file
Year Plans Participants Total Assets
2022 1 911 $97M
2023 1 978 $117M
2024 1 982 $135M

Nearby Other Plans in New York

Peer Other plans, same state, same plan type, ranked by total assets.

The Leukemia & Lymphoma Society, Inc. 403(b) Plan vs. nearby Other plans in New York, assets vs. participants

The Leukemia & Lymphoma Society, Inc. 403(b) Plan vs. nearby Other plans in New York, assets vs. participants Scatter plot of 6 data points. -200000200004000060000 -20246810 Total assets ($B) Participants The Leukemia & Lymph…Northwell Health 403…The Mount Sinai Medi…University of Roches…Memorial Sloan Kette…Retirement Plan for …
The Leukemia & Lymphoma Society, Inc. 403(b) Plan vs. nearby Other plans in New York, assets vs. participants

Similar-Sized Other Plans Nationally

Other plans in other states closest to The Leukemia & Lymphoma Society, Inc. 403(b) Plan by total assets, not by location.

Frequently Asked Questions

How did The Leukemia & Lymphoma Society, Inc. 403(b) Plan assets move in 2022?
The Leukemia & Lymphoma Society, Inc. 403(b) Plan pulled back noticeably - down 14.2% during 2022, from $113M to $97M. Reported net income was -$16M.
How have The Leukemia & Lymphoma Society, Inc. 403(b) Plan plan assets changed over time?
Across 3 plan years on file (2022-2024), The Leukemia & Lymphoma Society, Inc. 403(b) Plan's sponsor-wide assets grew 38.6%, from $97M to $135M.
Where does The Leukemia & Lymphoma Society, Inc. 403(b) Plan rank by assets among Form 5500 filers?
The Leukemia & Lymphoma Society, Inc. 403(b) Plan ranks in the 93rd percentile by end-of-year assets among 139,126 plans that reported assets for plan year 2022 (in the top 10% of all filed plans by assets).
Which Other plans are similar in size to The Leukemia & Lymphoma Society, Inc. 403(b) Plan?
Among Other plans in other states, the closest by assets is Princeton Day School 403(b) Plan in NJ ($97M, 298 participants).

Next read for The Leukemia & Lymphoma Society, Inc. 40…

Scale reading

Ways to act on The Leukemia & Lymphoma Society, Inc. 403(b) Plan's numbers.